Radiotherapy would promote the release of tumor-specific antigens and upregulate the expression of major histocompatibility complex (MHC) on cancer cells to promote tumor antigen presentation to cytotoxic T cells, and it would be easier for immunotherapy drugs to recognize these antigens and facilitate antigen-presenting cells to phagocytize damaged tumor cells [10]. This evidence concerns the gene HLA-C and neoplasm.